What do systematic reviews say?

Summary of findings: Specially formulated foods vs usual care

Summary of findings: Specially formulated foods showed no clear difference in not recovered compared with standard care (low certainty).

• Specially formulated foods for treating children with moderate acute malnutrition in low‐ and middle‐income countries 2013 · Cochrane Headline outcomes only
  RR 0.97 [0.74, 1.27]
  1 study · 1974 participants
  Low

Summary of findings: Specially formulated foods vs usual care

Summary of findings: Specially formulated foods probably leads to lower defaulted compared with standard care (moderate certainty).

• Specially formulated foods for treating children with moderate acute malnutrition in low‐ and middle‐income countries 2013 · Cochrane Headline outcomes only
  RR 0.3 [0.22, 0.39]
  1 study · 1974 participants
  Moderate

Summary of findings: Specially formulated foods vs usual care

• Specially formulated foods for treating children with moderate acute malnutrition in low‐ and middle‐income countries 2013 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 178 participants
  Low

Summary of findings: Specially formulated foods vs usual care

• Specially formulated foods for treating children with moderate acute malnutrition in low‐ and middle‐income countries 2013 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 1546 participants
  Moderate

Summary of findings: Specially formulated foods vs usual care

• Specially formulated foods for treating children with moderate acute malnutrition in low‐ and middle‐income countries 2013 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 178 participants
  Very low

Summary of findings: Specially formulated foods vs usual care

• Specially formulated foods for treating children with moderate acute malnutrition in low‐ and middle‐income countries 2013 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 1546 participants
  Low

Summary of findings: leflunomide + methotrexate vs methotrexate

• Leflunomide for the treatment of rheumatoid arthritis 2002 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 263 participants
  High

Summary of findings: leflunomide + methotrexate vs methotrexate

• Leflunomide for the treatment of rheumatoid arthritis 2002 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 263 participants
  Moderate

Summary of findings: leflunomide + methotrexate vs methotrexate

The review found no eligible studies for this question.

• Leflunomide for the treatment of rheumatoid arthritis 2002 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: leflunomide + methotrexate vs methotrexate

Summary of findings: leflunomide + methotrexate leads to higher ACR 50 at 6 months compared with methotrexate, 6 months (high certainty).

• Leflunomide for the treatment of rheumatoid arthritis 2002 · Cochrane Headline outcomes only
  RR 4.35 [2.09, 9.03]
  1 study · 263 participants
  High

Summary of findings: leflunomide + methotrexate vs methotrexate

• Leflunomide for the treatment of rheumatoid arthritis 2002 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 263 participants
  High

Summary of findings table ‐ Therapeutic exercise vs no treatment

• Therapeutic exercises for idiopathic scoliosis in adolescents 2024 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 52 participants
  Very low

Summary of findings table ‐ Therapeutic exercise vs bracing

• Therapeutic exercises for idiopathic scoliosis in adolescents 2024 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 60 participants
  Very low

Summary of findings table ‐ Therapeutic exercise vs bracing

• Therapeutic exercises for idiopathic scoliosis in adolescents 2024 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 60 participants
  Very low

Summary of findings table ‐ Therapeutic exercise vs bracing

• Therapeutic exercises for idiopathic scoliosis in adolescents 2024 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 60 participants
  Very low

Summary of findings table ‐ Therapeutic exercise vs no treatment

• Therapeutic exercises for idiopathic scoliosis in adolescents 2024 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 45 participants
  Low

Summary of findings table ‐ Therapeutic exercise vs no treatment

• Therapeutic exercises for idiopathic scoliosis in adolescents 2024 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 45 participants
  Low

Summary of findings table ‐ Therapeutic exercise vs no treatment

• Therapeutic exercises for idiopathic scoliosis in adolescents 2024 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 16 participants
  Low

Summary of findings table ‐ Therapeutic exercise vs no treatment

• Therapeutic exercises for idiopathic scoliosis in adolescents 2024 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 16 participants
  Low

Summary of findings table ‐ Therapeutic exercise vs no treatment

• Therapeutic exercises for idiopathic scoliosis in adolescents 2024 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 61 participants
  Low